Dr Reddy's plans multi-pronged strategy to build Russian business
This article was originally published in Scrip
Executive Summary
Dr Reddy's Laboratories appears set for a significant scale-up in Russia, including plans for a joint venture manufacturing facility, a prescription and OTx (prescription plus switch over-the-counter) thrust and a new in-licensing pact with Novartis deepening its engagement with one of its core international markets.